The Role and Future of Bioresorbable Vascular Scaffolds (BVS)
While Drug-Eluting Stents (DES) dominate the market, the US Percutaneous Coronary Intervention (PCI) Market is also seeing a smaller but rapidly growing segment: Bioresorbable Vascular Scaffolds (BVS). These devices, made of a material that is absorbed by the body over time, are designed to perform the function of a stent by holding the artery open, and then disappear, leaving behind a restored, natural vessel. This technology represents a significant advancement, as it avoids the long-term presence of a permanent metallic implant. While initial versions faced some clinical challenges, ongoing research and the development of new-generation BVS are addressing these issues. As the technology matures and long-term clinical data becomes available, bioresorbable scaffolds are expected to gain more widespread acceptance and offer a compelling alternative for younger patients who are concerned about having a permanent implant.
Link: Explore the potential of bioresorbable stents
FAQs
What are bioresorbable stents? They are devices that are absorbed by the body over time, leaving behind a natural, restored vessel without a permanent metallic implant.
What is their main advantage? Their main advantage is that they do not leave a permanent implant in the artery, which may be beneficial for long-term vessel function.